134 related articles for article (PubMed ID: 26507543)
1. Antiproliferative effects of γ-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cells.
Alawin OA; Ahmed RA; Ibrahim BA; Briski KP; Sylvester PW
J Nutr Biochem; 2016 Jan; 27():266-77. PubMed ID: 26507543
[TBL] [Abstract][Full Text] [Related]
2. γ-Tocotrienol-induced disruption of lipid rafts in human breast cancer cells is associated with a reduction in exosome heregulin content.
Alawin OA; Ahmed RA; Dronamraju V; Briski KP; Sylvester PW
J Nutr Biochem; 2017 Oct; 48():83-93. PubMed ID: 28797930
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl MR; Ayoub NM; Sylvester PW
Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
6. γ-Tocotrienol Suppression of the Warburg Effect Is Mediated by AMPK Activation in Human Breast Cancer Cells.
Dronamraju V; Ibrahim BA; Briski KP; Sylvester PW
Nutr Cancer; 2019; 71(7):1214-1228. PubMed ID: 30955359
[TBL] [Abstract][Full Text] [Related]
7. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
8. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
Algayadh IG; Dronamraju V; Sylvester PW
Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
Parajuli P; Tiwari RV; Sylvester PW
Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
Tiwari RV; Parajuli P; Sylvester PW
Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
Parajuli P; Tiwari RV; Sylvester PW
Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
Wali VB; Sylvester PW
Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
[TBL] [Abstract][Full Text] [Related]
13. Beta-Tocotrienol Exhibits More Cytotoxic Effects than Gamma-Tocotrienol on Breast Cancer Cells by Promoting Apoptosis via a P53-Independent PI3-Kinase Dependent Pathway.
Idriss M; Hodroj MH; Fakhoury R; Rizk S
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32283796
[TBL] [Abstract][Full Text] [Related]
14. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
15. γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death.
Tiwari RV; Parajuli P; Sylvester PW
Biochem Cell Biol; 2015 Aug; 93(4):306-20. PubMed ID: 25844964
[TBL] [Abstract][Full Text] [Related]
16. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
17. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
Ahmed RA; Alawin OA; Sylvester PW
Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
[TBL] [Abstract][Full Text] [Related]
18. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
Tiwari RV; Parajuli P; Sylvester PW
Exp Biol Med (Maywood); 2014 Jan; 239(1):33-44. PubMed ID: 24231340
[TBL] [Abstract][Full Text] [Related]
19. γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.
Ayoub NM; Bachawal SV; Sylvester PW
Cell Prolif; 2011 Dec; 44(6):516-26. PubMed ID: 21973114
[TBL] [Abstract][Full Text] [Related]
20. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]